<!DOCTYPE html>
<!-- saved from url=(0044)https://hosting.med.upenn.edu/akr/pdb-links/ -->
<html lang="en-US" "no-js"="" class=""><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><style type="text/css">@charset "UTF-8";[ng\:cloak],[ng-cloak],[data-ng-cloak],[x-ng-cloak],.ng-cloak,.x-ng-cloak,.ng-hide:not(.ng-hide-animate){display:none !important;}ng\:form{display:block;}.ng-animate-shim{visibility:hidden;}.ng-anchor{position:absolute;}</style>
        <!--<base href="/akr/">--><base href=".">
	
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<link rel="profile" href="http://gmpg.org/xfn/11">
		<script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script>
<title>Existing AKR Members – AKR Superfamily</title>
<link rel="dns-prefetch" href="https://s.w.org/">
<link rel="alternate" type="application/rss+xml" title="AKR Superfamily » Feed" href="https://hosting.med.upenn.edu/akr/feed/">
<link rel="alternate" type="application/rss+xml" title="AKR Superfamily » Comments Feed" href="https://hosting.med.upenn.edu/akr/comments/feed/">
		<script type="text/javascript">
			window._wpemojiSettings = {"baseUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.3\/72x72\/","ext":".png","svgUrl":"https:\/\/s.w.org\/images\/core\/emoji\/2.3\/svg\/","svgExt":".svg","source":{"concatemoji":"\/wp-includes\/js\/wp-emoji-release.min.js?ver=4.8.2"}};
			!function(a,b,c){function d(a){var b,c,d,e,f=String.fromCharCode;if(!k||!k.fillText)return!1;switch(k.clearRect(0,0,j.width,j.height),k.textBaseline="top",k.font="600 32px Arial",a){case"flag":return k.fillText(f(55356,56826,55356,56819),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,56826,8203,55356,56819),0,0),c=j.toDataURL(),b!==c&&(k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57332,56128,56423,56128,56418,56128,56421,56128,56430,56128,56423,56128,56447),0,0),b=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55356,57332,8203,56128,56423,8203,56128,56418,8203,56128,56421,8203,56128,56430,8203,56128,56423,8203,56128,56447),0,0),c=j.toDataURL(),b!==c);case"emoji4":return k.fillText(f(55358,56794,8205,9794,65039),0,0),d=j.toDataURL(),k.clearRect(0,0,j.width,j.height),k.fillText(f(55358,56794,8203,9794,65039),0,0),e=j.toDataURL(),d!==e}return!1}function e(a){var c=b.createElement("script");c.src=a,c.defer=c.type="text/javascript",b.getElementsByTagName("head")[0].appendChild(c)}var f,g,h,i,j=b.createElement("canvas"),k=j.getContext&&j.getContext("2d");for(i=Array("flag","emoji4"),c.supports={everything:!0,everythingExceptFlag:!0},h=0;h<i.length;h++)c.supports[i[h]]=d(i[h]),c.supports.everything=c.supports.everything&&c.supports[i[h]],"flag"!==i[h]&&(c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&c.supports[i[h]]);c.supports.everythingExceptFlag=c.supports.everythingExceptFlag&&!c.supports.flag,c.DOMReady=!1,c.readyCallback=function(){c.DOMReady=!0},c.supports.everything||(g=function(){c.readyCallback()},b.addEventListener?(b.addEventListener("DOMContentLoaded",g,!1),a.addEventListener("load",g,!1)):(a.attachEvent("onload",g),b.attachEvent("onreadystatechange",function(){"complete"===b.readyState&&c.readyCallback()})),f=c.source||{},f.concatemoji?e(f.concatemoji):f.wpemoji&&f.twemoji&&(e(f.twemoji),e(f.wpemoji)))}(window,document,window._wpemojiSettings);
		</script>
		<style type="text/css">
img.wp-smiley,
img.emoji {
	display: inline !important;
	border: none !important;
	box-shadow: none !important;
	height: 1em !important;
	width: 1em !important;
	margin: 0 .07em !important;
	vertical-align: -0.1em !important;
	background: none !important;
	padding: 0 !important;
}
</style>
<link rel="stylesheet" id="contact-form-7-css" href="./pdb_list_files/styles.css" type="text/css" media="all">
<link rel="stylesheet" id="genericons-css" href="./pdb_list_files/genericons.css" type="text/css" media="all">
<link rel="stylesheet" id="twentysomething-style-css" href="./pdb_list_files/style.css" type="text/css" media="all">
<style id="twentysomething-style-inline-css" type="text/css">

		/* Custom Page Background Color */
		.site {
			background-color: #f4f4f4;
		}

		mark,
		ins,
		button,
		button[disabled]:hover,
		button[disabled]:focus,
		input[type="button"],
		input[type="button"][disabled]:hover,
		input[type="button"][disabled]:focus,
		input[type="reset"],
		input[type="reset"][disabled]:hover,
		input[type="reset"][disabled]:focus,
		input[type="submit"],
		input[type="submit"][disabled]:hover,
		input[type="submit"][disabled]:focus,
		.menu-toggle.toggled-on,
		.menu-toggle.toggled-on:hover,
		.menu-toggle.toggled-on:focus,
		.pagination .prev,
		.pagination .next,
		.pagination .prev:hover,
		.pagination .prev:focus,
		.pagination .next:hover,
		.pagination .next:focus,
		.pagination .nav-links:before,
		.pagination .nav-links:after,
		.widget_calendar tbody a,
		.widget_calendar tbody a:hover,
		.widget_calendar tbody a:focus,
		.page-links a,
		.page-links a:hover,
		.page-links a:focus {
			color: #f4f4f4;
		}

		@media screen and (min-width: 56.875em) {
			.main-navigation ul ul li {
				background-color: #f4f4f4;
			}

			.main-navigation ul ul:after {
				border-top-color: #f4f4f4;
				border-bottom-color: #f4f4f4;
			}
		}


		/* Custom Link Color */
		.menu-toggle:hover,
		.menu-toggle:focus,
		a,
		.main-navigation a:hover,
		.main-navigation a:focus,
		.dropdown-toggle:hover,
		.dropdown-toggle:focus,
		.social-navigation a:hover:before,
		.social-navigation a:focus:before,
		.post-navigation a:hover .post-title,
		.post-navigation a:focus .post-title,
		.tagcloud a:hover,
		.tagcloud a:focus,
		.site-branding .site-title a:hover,
		.site-branding .site-title a:focus,
		.entry-title a:hover,
		.entry-title a:focus,
		.entry-footer a:hover,
		.entry-footer a:focus,
		.comment-metadata a:hover,
		.comment-metadata a:focus,
		.pingback .comment-edit-link:hover,
		.pingback .comment-edit-link:focus,
		.comment-reply-link,
		.comment-reply-link:hover,
		.comment-reply-link:focus,
		.required,
		.site-info a:hover,
		.site-info a:focus {
			color: #62006b;
		}

		mark,
		ins,
		button:hover,
		button:focus,
		input[type="button"]:hover,
		input[type="button"]:focus,
		input[type="reset"]:hover,
		input[type="reset"]:focus,
		input[type="submit"]:hover,
		input[type="submit"]:focus,
		.pagination .prev:hover,
		.pagination .prev:focus,
		.pagination .next:hover,
		.pagination .next:focus,
		.widget_calendar tbody a,
		.page-links a:hover,
		.page-links a:focus {
			background-color: #62006b;
		}

		input[type="text"]:focus,
		input[type="email"]:focus,
		input[type="url"]:focus,
		input[type="password"]:focus,
		input[type="search"]:focus,
		textarea:focus,
		.tagcloud a:hover,
		.tagcloud a:focus,
		.menu-toggle:hover,
		.menu-toggle:focus {
			border-color: #62006b;
		}

		@media screen and (min-width: 56.875em) {
			.main-navigation li:hover > a,
			.main-navigation li.focus > a {
				color: #62006b;
			}
		}


		/* Custom Main Text Color */
		body,
		blockquote cite,
		blockquote small,
		.main-navigation a,
		.menu-toggle,
		.dropdown-toggle,
		.social-navigation a,
		.post-navigation a,
		.pagination a:hover,
		.pagination a:focus,
		.widget-title a,
		.site-branding .site-title a,
		.entry-title a,
		.page-links > .page-links-title,
		.comment-author,
		.comment-reply-title small a:hover,
		.comment-reply-title small a:focus {
			color: #545c8c
		}

		blockquote,
		.menu-toggle.toggled-on,
		.menu-toggle.toggled-on:hover,
		.menu-toggle.toggled-on:focus,
		.post-navigation,
		.post-navigation div + div,
		.pagination,
		.widget,
		.page-header,
		.page-links a,
		.comments-title,
		.comment-reply-title {
			border-color: #545c8c;
		}

		button,
		button[disabled]:hover,
		button[disabled]:focus,
		input[type="button"],
		input[type="button"][disabled]:hover,
		input[type="button"][disabled]:focus,
		input[type="reset"],
		input[type="reset"][disabled]:hover,
		input[type="reset"][disabled]:focus,
		input[type="submit"],
		input[type="submit"][disabled]:hover,
		input[type="submit"][disabled]:focus,
		.menu-toggle.toggled-on,
		.menu-toggle.toggled-on:hover,
		.menu-toggle.toggled-on:focus,
		.pagination:before,
		.pagination:after,
		.pagination .prev,
		.pagination .next,
		.page-links a {
			background-color: #545c8c;
		}

		/* Border Color */
		fieldset,
		pre,
		abbr,
		acronym,
		table,
		th,
		td,
		input[type="text"],
		input[type="email"],
		input[type="url"],
		input[type="password"],
		input[type="search"],
		textarea,
		.main-navigation li,
		.main-navigation .primary-menu,
		.menu-toggle,
		.dropdown-toggle:after,
		.social-navigation a,
		.image-navigation,
		.comment-navigation,
		.tagcloud a,
		.entry-content,
		.entry-summary,
		.page-links a,
		.page-links > span,
		.comment-list article,
		.comment-list .pingback,
		.comment-list .trackback,
		.comment-reply-link,
		.no-comments,
		.widecolumn .mu_register .mu_alert {
			border-color: #545c8c; /* Fallback for IE7 and IE8 */
			border-color: rgba( 84, 92, 140, 0.2);
		}

		hr,
		code {
			background-color: #545c8c; /* Fallback for IE7 and IE8 */
			background-color: rgba( 84, 92, 140, 0.2);
		}

		@media screen and (min-width: 56.875em) {
			.main-navigation ul ul,
			.main-navigation ul ul li {
				border-color: rgba( 84, 92, 140, 0.2);
			}

			.main-navigation ul ul:before {
				border-top-color: rgba( 84, 92, 140, 0.2);
				border-bottom-color: rgba( 84, 92, 140, 0.2);
			}
		}

</style>
<!--[if lt IE 10]>
<link rel='stylesheet' id='twentysomething-ie-css'  href='/wp-content/themes/twentysomething/css/ie.css?ver=20160412' type='text/css' media='all' />
<![endif]-->
<!--[if lt IE 9]>
<link rel='stylesheet' id='twentysomething-ie8-css'  href='/wp-content/themes/twentysomething/css/ie8.css?ver=20160412' type='text/css' media='all' />
<![endif]-->
<!--[if lt IE 8]>
<link rel='stylesheet' id='twentysomething-ie7-css'  href='/wp-content/themes/twentysomething/css/ie7.css?ver=20160412' type='text/css' media='all' />
<![endif]-->
<link rel="stylesheet" id="angular-tree-control-css" href="./pdb_list_files/tree-control.css" type="text/css" media="all">
<link rel="stylesheet" id="angular-tree-control-attribute-css" href="./pdb_list_files/tree-control-attribute.css" type="text/css" media="all">
<script type="text/javascript" src="./pdb_list_files/jquery-1.11.1.min.js"></script>
<script type="text/javascript" src="./pdb_list_files/jquery.dataTables.min.js"></script>
<script type="text/javascript" src="./pdb_list_files/nav.js"></script>
<script type="text/javascript" src="./pdb_list_files/jquery.dataTables.min(1).js"></script>
<script type="text/javascript" src="./pdb_list_files/raphael-min.js"></script>
<script type="text/javascript" src="./pdb_list_files/jsphylosvg-min.js"></script>
<script type="text/javascript" src="./pdb_list_files/pv.min.js"></script>
<script type="text/javascript" src="./pdb_list_files/ngl.js"></script>
<script type="text/javascript" src="./pdb_list_files/msa.min.js"></script><style type="text/css">.biojs_msa_stage{cursor:default;line-height:normal;font-family:Helvetica}.biojs_msa_seqblock{cursor:move}.biojs_msa_layer{display:block;white-space:nowrap}.biojs_msa_labels{color:#000;display:inline-block;cursor:pointer;vertical-align:middle;overflow:hidden;text-overflow:clip}.biojs_msa_header,.biojs_msa_labels{white-space:nowrap;text-align:left}.biojs_msa_labelrow:before{content:'';display:inline-block;width:0;height:100%;vertical-align:middle}.biojs_msa_labelrow{height:100%}.biojs_msa_labelblock::-webkit-scrollbar,.biojs_msa_rheader::-webkit-scrollbar{//:none;width:7px;height:7px}.biojs_msa_labelblock::-webkit-scrollbar-thumb,.biojs_msa_rheader::-webkit-scrollbar-thumb{border-radius:4px;background-color:rgba(0,0,0,.5);box-shadow:0 0 1px hsla(0,0%,100%,.5)}.biojs_msa_marker{color:#999;white-space:nowrap}.biojs_msa_marker .msa-col-header{cursor:pointer;text-align:center}.biojs_msa_marker .msa-col-header:hover{color:red}.smenubar .smenubar_alink{background:#3498db;background-image:-webkit-linear-gradient(top,#3498db,#2980b9);background-image:linear-gradient(180deg,#3498db,#2980b9);border-radius:28px;font-family:Arial;color:#fff;padding:3px 10px;margin-left:10px;text-decoration:none}.smenubar{display:inline-block}.smenubar .smenubar_alink:hover{cursor:pointer}.smenu-dropdown{position:absolute;z-index:9999999;display:none}.smenu-dropdown .smenu-dropdown-menu,.smenu-dropdown .smenu-dropdown-panel{min-width:160px;max-width:360px;list-style:none;background:#fff;border:1px solid #ddd;border:1px solid rgba(0,0,0,.2);border-radius:6px;box-shadow:0 5px 10px rgba(0,0,0,.2);overflow:visible;padding:4px 0;margin:0}.smenu-dropdown .smenu-dropdown-panel{padding:10px}.smenu-dropdown.smenu-dropdown-scroll .smenu-dropdown-menu,.smenu-dropdown.smenu-dropdown-scroll .smenu-dropdown-panel{max-height:358px;overflow:auto}.smenu-dropdown .smenu-dropdown-menu LI{list-style:none;padding:0;margin:0;line-height:18px}.smenu-dropdown .smenu-dropdown-menu LABEL,.smenu-dropdown .smenu-dropdown-menu LI{display:block;color:#555;text-decoration:none;line-height:18px;padding:3px 15px;white-space:nowrap}.smenu-dropdown .smenu-dropdown-menu LABEL:hover,.smenu-dropdown .smenu-dropdown-menu LI:hover{background-color:#08c;color:#fff;cursor:pointer}.smenu-dropdown .smenu-dropdown-menu .smenu-dropdown-divider{font-size:1px;border-top:1px solid #e5e5e5;padding:0;margin:5px 0}.biojs_msa_div{position:relative}.biojs_msa_scale{position:absolute;bottom:0;right:0;background-color:#fff;box-shadow:0 2px 3px #999;border-radius:3px;margin:5px 0 0 auto;padding:5px;text-align:center}.biojs_msa_scale .msa-btngroup{margin:5px auto 0}.biojs_msa_scale [type=range]{cursor:pointer}.biojs_msa_scale .msa-btn-close{text-align:right;font-size:.8em;padding:2px}.biojs_msa_scale .msa-btn-open{background-color:#fff}.biojs_msa_scale .msa-hide{display:none}.msa-btn{cursor:pointer;font-size:1.1em;display:inline-block;padding:2px 8px;margin-bottom:0;border:1px solid transparent;border-radius:4px;box-sizing:border-box}.msa-btn:hover{background-color:#ddd}</style>
<script type="text/javascript" src="./pdb_list_files/angular.min.js"></script>
<script type="text/javascript" src="./pdb_list_files/angular-route.min.js"></script>
<script type="text/javascript" src="./pdb_list_files/angular-tree-control.js"></script>
<script type="text/javascript" src="./pdb_list_files/app.js"></script>
<!--[if lt IE 9]>
<script type='text/javascript' src='/wp-content/themes/twentysomething/js/html5.js?ver=3.7.3'></script>
<![endif]-->
<link rel="https://api.w.org/" href="https://hosting.med.upenn.edu/akr/wp-json/">
<link rel="EditURI" type="application/rsd+xml" title="RSD" href="https://hosting.med.upenn.edu/akr/xmlrpc.php?rsd">
<link rel="wlwmanifest" type="application/wlwmanifest+xml" href="https://hosting.med.upenn.edu/akr/wp-includes/wlwmanifest.xml">
<meta name="generator" content="WordPress 4.8.2">
<link rel="canonical" href="https://hosting.med.upenn.edu/akr/existing/">
<link rel="shortlink" href="https://hosting.med.upenn.edu/akr/?p=52">
<link rel="alternate" type="application/json+oembed" href="https://hosting.med.upenn.edu/akr/wp-json/oembed/1.0/embed?url=%2Fexisting%2F">
	<style type="text/css" id="twentysomething-header-css">
		.site-branding {
			margin: 0 auto 0 0;
		}

		.site-branding .site-title,
		.site-description {
			clip: rect(1px, 1px, 1px, 1px);
			position: absolute;
		}
	</style>
	<style type="text/css" id="custom-background-css">
body.custom-background { background-color: #6e6b7a; }
</style>
</head>

<body class="page-template-default page page-id-52 custom-background" data-new-gr-c-s-check-loaded="14.1057.0" data-gr-ext-installed="">
<div id="page" class="site">
	<div class="site-inner">
		<a class="skip-link screen-reader-text" href="https://hosting.med.upenn.edu/akr/#content">Skip to content</a>

		<header id="masthead" class="site-header" role="banner">
			<div class="site-header-main">
				<div class="site-branding">

											<p class="site-title"><a href="https://hosting.med.upenn.edu/akr/" rel="home">AKR Superfamily</a></p>
											<p class="site-description">Aldo-Keto Reductase Database</p>
									</div><!-- .site-branding -->

							</div><!-- .site-header-main -->

											<div class="header-image">
					<a href="https://hosting.med.upenn.edu/akr/" rel="home">
						<img src="./pdb_list_files/akrlogo-8.png" srcset="/akr/wp-content/uploads/2017/04/akrlogo-8-300x50.png 300w, /akr/wp-content/uploads/2017/04/akrlogo-8-768x128.png 768w, /akr/wp-content/uploads/2017/04/akrlogo-8-1024x171.png 1024w, /akr/wp-content/uploads/2017/04/akrlogo-8.png 1200w" sizes="(max-width: 709px) 85vw, (max-width: 909px) 81vw, (max-width: 1362px) 88vw, 1200px" width="1200" height="200" alt="AKR Superfamily">
					</a>
				</div><!-- .header-image -->
					</header><!-- .site-header -->

		<div id="content" class="site-content">

<div id="primary" class="content-area">
	<main id="main" class="site-main" role="main">

<article id="post-52" class="post-52 page type-page status-publish hentry">
	<header class="entry-header">
		<h1 class="entry-title">PDB List &amp; External Links</h1>	</header><!-- .entry-header -->


	<div class="entry-content">
<table id="family_members_table">
<thead>
<tr>
	  <th align="center" width="12">AKR</th>
	    <th align="center" width="37">Taxonomy</th>
	      <th align="center" nowrap="nowrap" width="40">Res.(Å)</th>
	        <th align="center" width="37">Complex</th>
		  <th align="center" width="37">PDB</th>
  </tr>
  <tr>
  <td>Akr1a1, Akr1a4</td>
  <td>Mus musculus</td>
  <td>1.64</td>
  <td>High resolution structure of mouse aldehyde reductase (AKR1a4) in its apo-form</td>
  <td><a href="https://www.rcsb.org/structure/4GAC">4GAC</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALDR1, ALR</td>
  <td>Homo sapiens</td>
  <td>2.48</td>
  <td>ALDEHYDE REDUCTASE</td>
  <td><a href="https://www.rcsb.org/structure/2ALR">2ALR</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>2.4</td>
  <td>ALDEHYDE REDUCTASE COMPLEXED WITH COFACTOR AND INHIBITOR, ALPHA CARBON ATOMS ONLY</td>
  <td><a href="https://www.rcsb.org/structure/1AE4">1AE4</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>2</td>
  <td>CRYSTAL STRUCTURE OF PORCINE ALDEHYDE REDUCTASE HOLOENZYME</td>
  <td><a href="https://www.rcsb.org/structure/1CWN">1CWN</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>2.2</td>
  <td>THE CRYSTAL STRUCTURE OF AN ALDEHYDE REDUCTASE Y50F MUTANT-NADP COMPLEX AND ITS IMPLICATIONS FOR SUBSTRATE BINDING</td>
  <td><a href="https://www.rcsb.org/structure/1HQT">1HQT</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>2.41</td>
  <td>Crystal structure of porcine aldehyde reductase ternary complex</td>
  <td><a href="https://www.rcsb.org/structure/3CV7">3CV7</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>1.99</td>
  <td>Porcine aldehyde reductase in ternary complex with inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/3FX4">3FX4</a></td>
  </tr>
  <tr>
  <td>AKR1A1, ALR, ALR1</td>
  <td>Sus scrofa</td>
  <td>1.85</td>
  <td>Structure of aldehyde reductase holoenzyme in complex with potent aldose reductase inhibitor Fidarestat: Implications for inhibitor binding and selectivity</td>
  <td><a href="https://www.rcsb.org/structure/3H4G">3H4G</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.4</td>
  <td>THE CRYSTAL STRUCTURE OF THE ALDOSE REDUCTASE NADPH BINARY COMPLEX</td>
  <td><a href="https://www.rcsb.org/structure/1ABN">1ABN</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>AN UNLIKELY SUGAR SUBSTRATE SITE IN THE 1.65 ANGSTROMS STRUCTURE OF THE HUMAN ALDOSE REDUCTASE HOLOENZYME IMPLICATED IN DIABETIC COMPLICATIONS</td>
  <td><a href="https://www.rcsb.org/structure/1ADS">1ADS</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>ALRESTATIN BOUND TO C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE</td>
  <td><a href="https://www.rcsb.org/structure/1AZ1">1AZ1</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.9</td>
  <td>CITRATE BOUND, C298A/W219Y MUTANT HUMAN ALDOSE REDUCTASE</td>
  <td><a href="https://www.rcsb.org/structure/1AZ2">1AZ2</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.8</td>
  <td>FIDARESTAT BOUND TO HUMAN ALDOSE REDUCTASE</td>
  <td><a href="https://www.rcsb.org/structure/1EF3">1EF3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>HUMAN ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR</td>
  <td><a href="https://www.rcsb.org/structure/1EL3">1EL3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.5</td>
  <td>CRYSTAL STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE INHIBITOR ZENARESTAT.</td>
  <td><a href="https://www.rcsb.org/structure/1IEI">1IEI</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>REFINED 1.8 ANGSTROMS STRUCTURE OF HUMAN ALDOSE REDUCTASE COMPLEXED WITH THE POTENT INHIBITOR ZOPOLRESTAT</td>
  <td><a href="https://www.rcsb.org/structure/1MAR">1MAR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.1</td>
  <td>Crystal structure of human Aldose Reductase complexed with NADP and Minalrestat</td>
  <td><a href="https://www.rcsb.org/structure/1PWL">1PWL</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.92</td>
  <td>Crystal structure of human Aldose Reductase complexed with NADP and Fidarestat</td>
  <td><a href="https://www.rcsb.org/structure/1PWM">1PWM</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal structure of human aldose reductase complexed with NADP and IDD552 at ph 5</td>
  <td><a href="https://www.rcsb.org/structure/1T40">1T40</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.05</td>
  <td>Crystal structure of human aldose reductase complexed with NADP and IDD552</td>
  <td><a href="https://www.rcsb.org/structure/1T41">1T41</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.66</td>
  <td>Human Aldose Reductase in complex with NADP+ and the inhibitor IDD594 at 0.66 Angstrom</td>
  <td><a href="https://www.rcsb.org/structure/1US0">1US0</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.4</td>
  <td>Crystal structure of Aldose Reductase with citrates bound in the active site</td>
  <td><a href="https://www.rcsb.org/structure/1X96">1X96</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.4</td>
  <td>Crystal structure of Aldose Reductase complexed with 2R4S (Stereoisomer of Fidarestat, 2S4S)</td>
  <td><a href="https://www.rcsb.org/structure/1X97">1X97</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.3</td>
  <td>Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S)</td>
  <td><a href="https://www.rcsb.org/structure/1X98">1X98</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.1</td>
  <td>Apo R268A human aldose reductase</td>
  <td><a href="https://www.rcsb.org/structure/1XGD">1XGD</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.04</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor lidorestat at 1.04 angstrom</td>
  <td><a href="https://www.rcsb.org/structure/1Z3N">1Z3N</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.43</td>
  <td>Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/1Z89">1Z89</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.95</td>
  <td>Human Aldose Reductase complexed with novel Sulfonyl-pyridazinone Inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/1Z8A">1Z8A</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.76</td>
  <td>AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE</td>
  <td><a href="https://www.rcsb.org/structure/2ACQ">2ACQ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.76</td>
  <td>AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE</td>
  <td><a href="https://www.rcsb.org/structure/2ACR">2ACR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.76</td>
  <td>AN ANION BINDING SITE IN HUMAN ALDOSE REDUCTASE: MECHANISTIC IMPLICATIONS FOR THE BINDING OF CITRATE, CACODYLATE, AND GLUCOSE-6-PHOSPHATE</td>
  <td><a href="https://www.rcsb.org/structure/2ACS">2ACS</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.76</td>
  <td>TYROSINE-48 IS THE PROTON DONOR AND HISTIDINE-110 DIRECTS SUBSTRATE STEREOCHEMICAL SELECTIVITY IN THE REDUCTION REACTION OF HUMAN ALDOSE REDUCTASE: ENZYME KINETICS AND THE CRYSTAL STRUCTURE OF THE Y48H MUTANT ENZYME</td>
  <td><a href="https://www.rcsb.org/structure/2ACU">2ACU</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>Aldose Reductase Mutant Leu 300 Pro complexed with Fidarestat</td>
  <td><a href="https://www.rcsb.org/structure/2AGT">2AGT</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Crystal structure of human Aldose Reductase complexed with zopolrestat after 3 days soaking (3days_soaked_1)</td>
  <td><a href="https://www.rcsb.org/structure/2DUX">2DUX</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Human Aldose Reductase complexed with inhibitor zopolrestat after 3 days soaking (3days_soaked_2)</td>
  <td><a href="https://www.rcsb.org/structure/2DUZ">2DUZ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.62</td>
  <td>Human Aldose Reductase complexed with zopolrestat after 6 days soaking(6days_soaked_2)</td>
  <td><a href="https://www.rcsb.org/structure/2DV0">2DV0</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.94</td>
  <td>Aldose reductase tertiary complex with NADPH and DEG</td>
  <td><a href="https://www.rcsb.org/structure/2F2K">2F2K</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.48</td>
  <td>Human Aldose reductase complexed with inhibitor zopolrestat at 1.48 A(1 day soaking).</td>
  <td><a href="https://www.rcsb.org/structure/2FZ8">2FZ8</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Human Aldose Reductase complexed with inhibitor zopolrestat after six days soaking.</td>
  <td><a href="https://www.rcsb.org/structure/2FZ9">2FZ9</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.5</td>
  <td>Human Aldose Reductase complexed with four tolrestat molecules at 1.5 A resolution.</td>
  <td><a href="https://www.rcsb.org/structure/2FZB">2FZB</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.08</td>
  <td>Human aldose reductase complexed with tolrestat at 1.08 A resolution.</td>
  <td><a href="https://www.rcsb.org/structure/2FZD">2FZD</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.59</td>
  <td>Human Aldose Reductase complexed with inhibitor zopolrestat after three days soaking (3days_soaked_3)</td>
  <td><a href="https://www.rcsb.org/structure/2HV5">2HV5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.58</td>
  <td>Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation after one day (1day_cocryst)</td>
  <td><a href="https://www.rcsb.org/structure/2HVN">2HVN</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human Aldose Reductase-zopolrestat complex obtained by cocrystallisation (10days_cocryst)</td>
  <td><a href="https://www.rcsb.org/structure/2HVO">2HVO</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.81</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 15K</td>
  <td><a href="https://www.rcsb.org/structure/2I16">2I16</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.81</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594 at temperature of 60K</td>
  <td><a href="https://www.rcsb.org/structure/2I17">2I17</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.43</td>
  <td>Aldose reductase complexed with nitrophenyl-oxadiazol type inhibitor at 1.43 A</td>
  <td><a href="https://www.rcsb.org/structure/2IKG">2IKG</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase complexed with nitrofuryl-oxadiazol inhibitor at 1.55 A</td>
  <td><a href="https://www.rcsb.org/structure/2IKH">2IKH</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.47</td>
  <td>Human aldose reductase complexed with halogenated IDD-type inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/2IKI">2IKI</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase complexed with nitro-substituted IDD-type inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/2IKJ">2IKJ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal Structure of Aldose Reductase complexed with Phenylacetic Acid</td>
  <td><a href="https://www.rcsb.org/structure/2INE">2INE</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.95</td>
  <td>Crystal Structure of Aldose Reductase complexed with 2-Hydroxyphenylacetic Acid</td>
  <td><a href="https://www.rcsb.org/structure/2INZ">2INZ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of C298A W219Y Aldose Reductase complexed with Dichlorophenylacetic acid</td>
  <td><a href="https://www.rcsb.org/structure/2IPW">2IPW</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.95</td>
  <td>Crystal Structure of Aldose Reductase complexed with Hexanoic Acid</td>
  <td><a href="https://www.rcsb.org/structure/2IQ0">2IQ0</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of Aldose Reductase complexed with Lipoic Acid</td>
  <td><a href="https://www.rcsb.org/structure/2IQD">2IQD</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Crystal Structure of Aldose Reductase complexed with Dichlorophenylacetic acid</td>
  <td><a href="https://www.rcsb.org/structure/2IS7">2IS7</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of C298A W219Y Aldose Reductase complexed with Phenylacetic Acid</td>
  <td><a href="https://www.rcsb.org/structure/2ISF">2ISF</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.82</td>
  <td>Human aldose reductase in complex with NADP and citrate at 0.82 angstrom</td>
  <td><a href="https://www.rcsb.org/structure/2J8T">2J8T</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (3)</td>
  <td><a href="https://www.rcsb.org/structure/2NVC">2NVC</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human Aldose Reductase complexed with novel naphtho[1,2-d]isothiazole acetic acid derivative (2)</td>
  <td><a href="https://www.rcsb.org/structure/2NVD">2NVD</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Human aldose reductase mutant V47I complexed with zopolrestat</td>
  <td><a href="https://www.rcsb.org/structure/2PD5">2PD5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase mutant V47I complexed with fidarestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PD9">2PD9</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Human aldose reductase mutant F121P complexed with zopolrestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDB">2PDB</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human aldose reductase mutant F121P complexed with IDD393.</td>
  <td><a href="https://www.rcsb.org/structure/2PDC">2PDC</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.56</td>
  <td>Human aldose reductase mutant L300P complexed with zopolrestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDF">2PDF</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.42</td>
  <td>Human aldose reductase with uracil-type inhibitor at 1.42A.</td>
  <td><a href="https://www.rcsb.org/structure/2PDG">2PDG</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.45</td>
  <td>Human aldose reductase mutant L300P complexed with uracil-type inhibitor at 1.45 A.</td>
  <td><a href="https://www.rcsb.org/structure/2PDH">2PDH</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase mutant L300A complexed with zopolrestat at 1.55 A.</td>
  <td><a href="https://www.rcsb.org/structure/2PDI">2PDI</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.57</td>
  <td>Human aldose reductase mutant L300A complexed with IDD393.</td>
  <td><a href="https://www.rcsb.org/structure/2PDJ">2PDJ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase mutant L301M complexed with sorbinil.</td>
  <td><a href="https://www.rcsb.org/structure/2PDK">2PDK</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.47</td>
  <td>Human aldose reductase mutant L301M complexed with tolrestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDL">2PDL</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Human aldose reductase mutant S302R complexed with zopolrestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDM">2PDM</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Human aldose reductase mutant S302R complexed with uracil-type inhibitor.</td>
  <td><a href="https://www.rcsb.org/structure/2PDN">2PDN</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human aldose reductase mutant S302R complexed with IDD 393.</td>
  <td><a href="https://www.rcsb.org/structure/2PDP">2PDP</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.73</td>
  <td>Human aldose reductase mutant C303D complexed with uracil-type inhibitor.</td>
  <td><a href="https://www.rcsb.org/structure/2PDQ">2PDQ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase mutant C303D complexed with IDD393.</td>
  <td><a href="https://www.rcsb.org/structure/2PDU">2PDU</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human aldose reductase mutant C303D complexed with fidarestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDW">2PDW</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human aldose reductase double mutant S302R-C303D complexed with zopolrestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDX">2PDX</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human aldose reductase double mutant S302R-C303D complexed with fidarestat.</td>
  <td><a href="https://www.rcsb.org/structure/2PDY">2PDY</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.9</td>
  <td>Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution exceeds concentration of IDD594.</td>
  <td><a href="https://www.rcsb.org/structure/2PEV">2PEV</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.85</td>
  <td>Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is equal to concentration of IDD594.</td>
  <td><a href="https://www.rcsb.org/structure/2PF8">2PF8</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.85</td>
  <td>Complex of Aldose Reductase with NADP+ and simaltaneously bound competetive inhibitors Fidarestat and IDD594. Concentration of Fidarestat in soaking solution is less than concentration of IDD594.</td>
  <td><a href="https://www.rcsb.org/structure/2PFH">2PFH</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>The crystallographic structure of Aldose Reductase IDD393 complex confirms Leu300 as a specificity determinant</td>
  <td><a href="https://www.rcsb.org/structure/2PZN">2PZN</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.8</td>
  <td>Perdeuterated alr2 in complex with idd594</td>
  <td><a href="https://www.rcsb.org/structure/2QXW">2QXW</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td></td>
  <td>Human Aldose Reductase structure</td>
  <td><a href="https://www.rcsb.org/structure/2R24">2R24</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.78</td>
  <td>Crystal structure of Aldose Reductase complexed with 2S4R (Stereoisomer of Fidarestat, 2S4S) at 0.78 A</td>
  <td><a href="https://www.rcsb.org/structure/3BCJ">3BCJ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.45</td>
  <td>Aldose Reductase in complex with novel biarylic inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/3DN5">3DN5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Human aldose reductase complexed with IDD 740 inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/3G5E">3G5E</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. First stage of radiation damage</td>
  <td><a href="https://www.rcsb.org/structure/3GHR">3GHR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Second stage of radiation damage.</td>
  <td><a href="https://www.rcsb.org/structure/3GHS">3GHS</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.1</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Third stage of radiation damage.</td>
  <td><a href="https://www.rcsb.org/structure/3GHT">3GHT</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.2</td>
  <td>Human aldose reductase in complex with NADP+ and the inhibitor IDD594. Investigation of global effects of radiation damage on protein structure. Forth stage of radiation damage.</td>
  <td><a href="https://www.rcsb.org/structure/3GHU">3GHU</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.1</td>
  <td>Human aldose reductase mutant T113C complexed with IDD594</td>
  <td><a href="https://www.rcsb.org/structure/3LBO">3LBO</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.27</td>
  <td>Human aldose reductase mutant T113S complexed with IDD594</td>
  <td><a href="https://www.rcsb.org/structure/3LD5">3LD5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.21</td>
  <td>Human Aldose Reductase mutant T113S complexed with Zopolrestat</td>
  <td><a href="https://www.rcsb.org/structure/3LEN">3LEN</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.99</td>
  <td>Human Aldose Reductase mutant T113C in complex with IDD388</td>
  <td><a href="https://www.rcsb.org/structure/3LEP">3LEP</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.35</td>
  <td>Human aldose reductase mutant T113A complexed with IDD388</td>
  <td><a href="https://www.rcsb.org/structure/3LQG">3LQG</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.13</td>
  <td>Human Aldose Reductase mutant T113A complexed with IDD 594</td>
  <td><a href="https://www.rcsb.org/structure/3LQL">3LQL</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.03</td>
  <td>Human aldose reductase mutant T113S complexed with IDD388</td>
  <td><a href="https://www.rcsb.org/structure/3LZ3">3LZ3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.95</td>
  <td>Human aldose reductase mutant T113V complexed with IDD594</td>
  <td><a href="https://www.rcsb.org/structure/3LZ5">3LZ5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.07</td>
  <td>Human Aldose Reductase mutant T113V in complex with Zopolrestat</td>
  <td><a href="https://www.rcsb.org/structure/3M0I">3M0I</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.94</td>
  <td>Human Aldose Reductase mutant T113V complexed with IDD388</td>
  <td><a href="https://www.rcsb.org/structure/3M4H">3M4H</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.3</td>
  <td>Human aldose reductase mutant T113V complexed with IDD393</td>
  <td><a href="https://www.rcsb.org/structure/3M64">3M64</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human Aldose Reductase mutant T113A complexed with Zopolrestat</td>
  <td><a href="https://www.rcsb.org/structure/3MB9">3MB9</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.14</td>
  <td>Human Aldose Reductase mutant T113V in complex with IDD393 crystallized in spacegroup P1</td>
  <td><a href="https://www.rcsb.org/structure/3MC5">3MC5</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.45</td>
  <td>Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mutant after extensive radiation dose</td>
  <td><a href="https://www.rcsb.org/structure/3ONB">3ONB</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.06</td>
  <td>Bond breakage and relocation of a covalently bound bromine of IDD594 in a complex with hAR T113A mutant after moderate radiation dose</td>
  <td><a href="https://www.rcsb.org/structure/3ONC">3ONC</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.69</td>
  <td>Novel Benzothiazepine Inhibitor in Complex with human Aldose Reductase</td>
  <td><a href="https://www.rcsb.org/structure/3P2V">3P2V</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.09</td>
  <td>Human Aldose Reductase in Complex with NADP+ in Space Group P212121</td>
  <td><a href="https://www.rcsb.org/structure/3Q65">3Q65</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>Human Aldose Reductase C298S mutant in Complex with NADP+ in Space Group P212121</td>
  <td><a href="https://www.rcsb.org/structure/3Q67">3Q67</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal Structure of Human Aldose Reductase Complexed with Sulindac Sulfone</td>
  <td><a href="https://www.rcsb.org/structure/3RX2">3RX2</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal Structure of Human Aldose Reductase Complexed with Sulindac</td>
  <td><a href="https://www.rcsb.org/structure/3RX3">3RX3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of Human Aldose Reductase complexed with Sulindac Sulfide</td>
  <td><a href="https://www.rcsb.org/structure/3RX4">3RX4</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal Structure of Human Aldose Reductase Complexed with Tolmetin</td>
  <td><a href="https://www.rcsb.org/structure/3S3G">3S3G</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.28</td>
  <td>Human aldose reductase in complex with a nitrile-containing IDD inhibitor</td>
  <td><a href="https://www.rcsb.org/structure/3T42">3T42</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>Aldose reductase in complex with NSAID-type inhibitor at 1.0 A resolution</td>
  <td><a href="https://www.rcsb.org/structure/3U2C">3U2C</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Aldose reductase complexed with a nitro compound</td>
  <td><a href="https://www.rcsb.org/structure/3V35">3V35</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Aldose reductase complexed with glceraldehyde</td>
  <td><a href="https://www.rcsb.org/structure/3V36">3V36</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.9</td>
  <td>Complex of Aldose Reductase with inhibitor IDD 1219</td>
  <td><a href="https://www.rcsb.org/structure/4GCA">4GCA</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.85</td>
  <td>Crystal structure of human Aldose Reductase complexed with NADP+ and JF0064</td>
  <td><a href="https://www.rcsb.org/structure/4IGS">4IGS</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure Of Aldose Reductase (AKR1B1) Complexed With NADP+ And Epalrestat</td>
  <td><a href="https://www.rcsb.org/structure/4JIR">4JIR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.84</td>
  <td>Crystal structure of human AR complexed with NADP+ and {2-[(4-bromobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LAU">4LAU</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.85</td>
  <td>Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(4-iodobenzyl)carbamoyl]phenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LAZ">4LAZ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.8</td>
  <td>Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2-fluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LB3">4LB3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.8</td>
  <td>Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,3,5,6-tetrafluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LB4">4LB4</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.8</td>
  <td>Crystal structure of human AR complexed with NADP+ and {5-chloro-2-[(2,6-difluoro-4-iodobenzyl)carbamoyl]phenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LBR">4LBR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.76</td>
  <td>Crystal structure of human AR complexed with NADP+ and {2-[(4-bromo-2,6-difluorobenzyl)carbamoyl]-5-chlorophenoxy}acetic acid</td>
  <td><a href="https://www.rcsb.org/structure/4LBS">4LBS</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.12</td>
  <td>Human Aldose Reductase complexed with Schl7764 at 1.12 A</td>
  <td><a href="https://www.rcsb.org/structure/4NKC">4NKC</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.06</td>
  <td>Human Aldose Reductase complexed with Schl7802 at 1.06 A</td>
  <td><a href="https://www.rcsb.org/structure/4PR4">4PR4</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.01</td>
  <td>Human Aldose Reductase complexed with Schl7815 ((3-[3-(5-NITROFURAN-2-YL)PHENYL]PROPANOIC ACID)at 1.01 A</td>
  <td><a href="https://www.rcsb.org/structure/4PRR">4PRR</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.96</td>
  <td>Human Aldose Reductase complexed with Schl12221 ({2-[5-(3-NITROPHENYL)FURAN-2-YL]PHENYL}ACETIC ACID) at 0.96 A</td>
  <td><a href="https://www.rcsb.org/structure/4PRT">4PRT</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.14</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure (2-(2-carbamoyl-5-fluoro-phenoxy)acetic acid) at 1.14 A</td>
  <td><a href="https://www.rcsb.org/structure/4PUU">4PUU</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.12</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure (2-[5-fluoro-2-(prop-2-ynylcarbamoyl)phenoxy]acetic acid) at 1.12 A</td>
  <td><a href="https://www.rcsb.org/structure/4PUW">4PUW</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.19</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure ([2-(benzylcarbamoyl)-5-fluorophenoxy]acetic acid) at 1.19 A</td>
  <td><a href="https://www.rcsb.org/structure/4Q7B">4Q7B</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.98</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) at 0.98 A</td>
  <td><a href="https://www.rcsb.org/structure/4QBX">4QBX</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.05</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure (2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-5-fluoro-phenoxy]acetic acid) at 1.05 A</td>
  <td><a href="https://www.rcsb.org/structure/4QR6">4QR6</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.26</td>
  <td>Human Aldose Reductase complexed with a ligand with a new scaffold at 1.26 A</td>
  <td><a href="https://www.rcsb.org/structure/4QX4">4QX4</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.87</td>
  <td>Crystal structure of human AR complexed with NADP+ and AK198</td>
  <td><a href="https://www.rcsb.org/structure/4QXI">4QXI</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.2</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure at 1.20 A (1)</td>
  <td><a href="https://www.rcsb.org/structure/4RPQ">4RPQ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1</td>
  <td>Crystal structure of human Aldose Reductase complexed with NADP+ and JF0048</td>
  <td><a href="https://www.rcsb.org/structure/4XZH">4XZH</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>2.45</td>
  <td>Crystal structure of human Aldose Reductase complexed with NADP+ and JF0049</td>
  <td><a href="https://www.rcsb.org/structure/4XZI">4XZI</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.07</td>
  <td>Human Aldose Reductase complexed with a ligand with an IDD structure (2) at 1.07 A.</td>
  <td><a href="https://www.rcsb.org/structure/4YS1">4YS1</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.02</td>
  <td>Human Aldose Reductase complexed with Schl12134 (3-[5-(3-nitrophenyl)-2-thienyl]propanoic acid) at 1.02 A</td>
  <td><a href="https://www.rcsb.org/structure/4YU1">4YU1</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>Human Aldose Reductase in Complex with NADP+ and WY14643 in Space Group P212121</td>
  <td><a href="https://www.rcsb.org/structure/5HA7">5HA7</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.94</td>
  <td>Crystal structure of human AKR1B1 complexed with NADP+ and compound 37</td>
  <td><a href="https://www.rcsb.org/structure/5OU0">5OU0</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.96</td>
  <td>Crystal structure of human AKR1B1 complexed with NADP+ and compound 39</td>
  <td><a href="https://www.rcsb.org/structure/5OUJ">5OUJ</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALDR1</td>
  <td>Homo sapiens</td>
  <td>0.96</td>
  <td>Crystal structure of human AKR1B1 complexed with NADP+ and compound 41</td>
  <td><a href="https://www.rcsb.org/structure/5OUK">5OUK</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALR2</td>
  <td>Sus scrofa</td>
  <td>2.3</td>
  <td>PIG ALDOSE REDUCTASE COMPLEXED WITH SORBINIL</td>
  <td><a href="https://www.rcsb.org/structure/1AH0">1AH0</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALR2</td>
  <td>Sus scrofa</td>
  <td>2.3</td>
  <td>ALDOSE REDUCTASE COMPLEXED WITH TOLRESTAT INHIBITOR</td>
  <td><a href="https://www.rcsb.org/structure/1AH3">1AH3</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALR2</td>
  <td>Sus scrofa</td>
  <td>2</td>
  <td>PIG ALDOSE REDUCTASE, HOLO FORM</td>
  <td><a href="https://www.rcsb.org/structure/1AH4">1AH4</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALR2</td>
  <td>Sus scrofa</td>
  <td>3</td>
  <td>NOVEL NADPH-BINDING DOMAIN REVEALED BY THE CRYSTAL STRUCTURE OF ALDOSE REDUCTASE</td>
  <td><a href="https://www.rcsb.org/structure/1DLA">1DLA</a></td>
  </tr>
  <tr>
  <td>AKR1B1, ALR2</td>
  <td>Sus scrofa</td>
  <td>2.2</td>
  <td>PIG ALDOSE REDUCTASE COMPLEXED WITH IDD384 INHIBITOR</td>
  <td><a href="https://www.rcsb.org/structure/1EKO">1EKO</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.25</td>
  <td>Crystal Structure Of AKR1B10 Complexed With NADP+ And Tolrestat</td>
  <td><a href="https://www.rcsb.org/structure/1ZUA">1ZUA</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.94</td>
  <td>Human AKR1B10 mutant V301L complexed with NADP+ and sorbinil</td>
  <td><a href="https://www.rcsb.org/structure/4GA8">4GA8</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>Human AKR1B10 mutant V301L complexed with NADP+ and fidarestat</td>
  <td><a href="https://www.rcsb.org/structure/4GAB">4GAB</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.1</td>
  <td>Crystal structure of AKR1B10 complexed with NADP+ and Caffeic acid phenethyl ester</td>
  <td><a href="https://www.rcsb.org/structure/4GQ0">4GQ0</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.92</td>
  <td>Crystal structure of AKR1B10 complexed with NADP+</td>
  <td><a href="https://www.rcsb.org/structure/4GQG">4GQG</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.1</td>
  <td>Crystal Structure Of AKR1B10 Complexed With NADP+ And Flufenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/4I5X">4I5X</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and JF0064</td>
  <td><a href="https://www.rcsb.org/structure/4ICC">4ICC</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.3</td>
  <td>Crystal Structure Of AKR1B10 Complexed With NADP+ And Epalrestat</td>
  <td><a href="https://www.rcsb.org/structure/4JIH">4JIH</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.2</td>
  <td>Crystal Structure Of AKR1B10 Complexed With NADP+ And Zopolrestat</td>
  <td><a href="https://www.rcsb.org/structure/4JII">4JII</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.45</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and sulindac</td>
  <td><a href="https://www.rcsb.org/structure/4WEV">4WEV</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and JF0049</td>
  <td><a href="https://www.rcsb.org/structure/4XZL">4XZL</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Crystal structure of the methylated wild-type AKR1B10 holoenzyme</td>
  <td><a href="https://www.rcsb.org/structure/4XZM">4XZM</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Crystal structure of the methylated K125R/V301L AKR1B10 Holoenzyme</td>
  <td><a href="https://www.rcsb.org/structure/4XZN">4XZN</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.05</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK181</td>
  <td><a href="https://www.rcsb.org/structure/5LIK">5LIK</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor IDD388</td>
  <td><a href="https://www.rcsb.org/structure/5LIU">5LIU</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK319</td>
  <td><a href="https://www.rcsb.org/structure/5LIW">5LIW</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.95</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK184</td>
  <td><a href="https://www.rcsb.org/structure/5LIX">5LIX</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.05</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the inhibitor MK204</td>
  <td><a href="https://www.rcsb.org/structure/5LIY">5LIY</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>1.5</td>
  <td>Crystal structure of human AKR1B10 complexed with NADP+ and the synthetic retinoid UVI2008</td>
  <td><a href="https://www.rcsb.org/structure/5M2F">5M2F</a></td>
  </tr>
  <tr>
  <td>AKR1B10, AKR1B11</td>
  <td>Homo sapiens</td>
  <td>2.5</td>
  <td>Crystal structure of AKR1B10 in complex with NADP+ and Androst-4-ene-3-beta-6-alpha-diol</td>
  <td><a href="https://www.rcsb.org/structure/5Y7N">5Y7N</a></td>
  </tr>
  <tr>
  <td>Akr1b7, Akr1b14</td>
  <td>Rattus norvegicus</td>
  <td>1.86</td>
  <td>Crystal Structure of AKR1B14 in complex with NADP</td>
  <td><a href="https://www.rcsb.org/structure/3O3R">3O3R</a></td>
  </tr>
  <tr>
  <td>Akr1b7, Akr1b14</td>
  <td>Rattus norvegicus</td>
  <td>1.87</td>
  <td>Crystal structure of mutant His269Arg AKR1B14</td>
  <td><a href="https://www.rcsb.org/structure/3QKZ">3QKZ</a></td>
  </tr>
  <tr>
  <td>AKR1B8</td>
  <td>Cricetulus griseus</td>
  <td>2.4</td>
  <td>CHO REDUCTASE WITH NADP+</td>
  <td><a href="https://www.rcsb.org/structure/1C9W">1C9W</a></td>
  </tr>
  <tr>
  <td>AKR1C1, DDH, DDH1</td>
  <td>Homo sapiens</td>
  <td>1.59</td>
  <td>Crystal structure of human 20alpha-HSD in ternary complex with NADP and 20alpha-hydroxy-progesterone</td>
  <td><a href="https://www.rcsb.org/structure/1MRQ">1MRQ</a></td>
  </tr>
  <tr>
  <td>AKR1C1, DDH, DDH1</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal structure of AKR1C1 in complex with NADP and 3,5-dichlorosalicylic acid</td>
  <td><a href="https://www.rcsb.org/structure/3C3U">3C3U</a></td>
  </tr>
  <tr>
  <td>AKR1C1, DDH, DDH1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal structure of AKR1C1 L308V mutant in complex with NADP and 3,5-dichlorosalicylic acid</td>
  <td><a href="https://www.rcsb.org/structure/3GUG">3GUG</a></td>
  </tr>
  <tr>
  <td>AKR1C1, DDH, DDH1</td>
  <td>Homo sapiens</td>
  <td>1.87</td>
  <td>Crystal structure of AKR1C1 in complex with NADP and 5-Phenyl,3-chlorosalicylic acid</td>
  <td><a href="https://www.rcsb.org/structure/3NTY">3NTY</a></td>
  </tr>
  <tr>
  <td>AKR1C1, DDH, DDH1</td>
  <td>Homo sapiens</td>
  <td>2.6</td>
  <td>Crystal Structure of AKR1C1 complexed with glibenclamide</td>
  <td><a href="https://www.rcsb.org/structure/4YVP">4YVP</a></td>
  </tr>
  <tr>
  <td>Akr1c13</td>
  <td>Mus musculus</td>
  <td>1.5</td>
  <td>Crystal Structure of mouse RECON (AKR1C13) in complex with Cyclic di-AMP</td>
  <td><a href="https://www.rcsb.org/structure/5UXF">5UXF</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>3</td>
  <td>Crystal Structure of Human Type III 3-alpha-Hydroxysteroid Dehydrogenase/Bile Acid Binding Protein (AKR1C2) Complexed with NADP+ and Ursodeoxycholate</td>
  <td><a href="https://www.rcsb.org/structure/1IHI">1IHI</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.25</td>
  <td>Human 3alpha-HSD type 3 in Ternary Complex with NADP and Testosterone</td>
  <td><a href="https://www.rcsb.org/structure/1J96">1J96</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H), citrate and acetate molecules</td>
  <td><a href="https://www.rcsb.org/structure/1XJB">1XJB</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of human type 3 3alpha-hydroxysteroid dehydrogenase in complex with NADP(H)</td>
  <td><a href="https://www.rcsb.org/structure/2HDJ">2HDJ</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal structure of h3alpha-hydroxysteroid dehydrogenase type 3 mutant Y24A in complex with NADP+ and epi-testosterone</td>
  <td><a href="https://www.rcsb.org/structure/2IPJ">2IPJ</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>AKR1C2 complex with naproxen</td>
  <td><a href="https://www.rcsb.org/structure/4JQ1">4JQ1</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>AKR1C2 complex with sulindac</td>
  <td><a href="https://www.rcsb.org/structure/4JQ2">4JQ2</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>AKR1C2 complex with zomepirac</td>
  <td><a href="https://www.rcsb.org/structure/4JQ3">4JQ3</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.52</td>
  <td>AKR1C2 complex with indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/4JQ4">4JQ4</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.45</td>
  <td>AKR1C2 complex with mefenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/4JQA">4JQA</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>AKR1C2 complex with flurbiprofen</td>
  <td><a href="https://www.rcsb.org/structure/4JTQ">4JTQ</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.3</td>
  <td>AKR1C2 complex with ibuprofen</td>
  <td><a href="https://www.rcsb.org/structure/4JTR">4JTR</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>2.2</td>
  <td>Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 in Complex with NADP+ and Progesterone</td>
  <td><a href="https://www.rcsb.org/structure/4L1W">4L1W</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structuer of Human 3-alpha Hydroxysteroid Dehydrogenase Type 3 V54L Mutant in Complex with NADP+ and Progesterone</td>
  <td><a href="https://www.rcsb.org/structure/4L1X">4L1X</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.2</td>
  <td>Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one</td>
  <td><a href="https://www.rcsb.org/structure/4XO6">4XO6</a></td>
  </tr>
  <tr>
  <td>AKR1C2, DDH2</td>
  <td>Homo sapiens</td>
  <td>1.75</td>
  <td>Crystal structure of human 3-alpha hydroxysteroid dehydrogenase type 3 in complex with NADP+, 5alpha-androstan-3,17-dione and (3beta, 5alpha)-3-hydroxyandrostan-17-one</td>
  <td><a href="https://www.rcsb.org/structure/4XO7">4XO7</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.69</td>
  <td>Structure of prostaglandin F synthase with prostaglandin D2</td>
  <td><a href="https://www.rcsb.org/structure/1RY0">1RY0</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.69</td>
  <td>Prostaglandin F synthase complexed with NADPH and rutin</td>
  <td><a href="https://www.rcsb.org/structure/1RY8">1RY8</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.2</td>
  <td>Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/1S1P">1S1P</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structures of prostaglandin D2 11-ketoreductase (AKR1C3) in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/1S1R">1S1R</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/1S2A">1S2A</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal structures of prostaglandin D2 11-ketoreductase in complex with the non-steroidal anti-inflammatory drugs flufenamic acid and indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/1S2C">1S2C</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) complexed with delta4-androstene-3,17-dione and NADP</td>
  <td><a href="https://www.rcsb.org/structure/1XF0">1XF0</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.3</td>
  <td>Crystal structure of human androgenic 17beta-hydroxysteroid dehydrogenase type 5 in complexed with a potent inhibitor EM1404</td>
  <td><a href="https://www.rcsb.org/structure/1ZQ5">1ZQ5</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of prostaglandin F synathase containing bimatoprost</td>
  <td><a href="https://www.rcsb.org/structure/2F38">2F38</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.35</td>
  <td>Crystal structure of human 17bet a-hydroxysteroid dehydrogenase type 5 in complexes with PEG and NADP</td>
  <td><a href="https://www.rcsb.org/structure/2FGB">2FGB</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>AKR1C3 complexed with mefenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/3R43">3R43</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.3</td>
  <td>AKR1C3 complex with naproxen</td>
  <td><a href="https://www.rcsb.org/structure/3R58">3R58</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.95</td>
  <td>AKR1C3 complex with meclofenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/3R6I">3R6I</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.1</td>
  <td>AKR1C3 complex with sulindac</td>
  <td><a href="https://www.rcsb.org/structure/3R7M">3R7M</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>AKR1C3 complex with ibuprofen</td>
  <td><a href="https://www.rcsb.org/structure/3R8G">3R8G</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>AKR1C3 complex with zomepirac</td>
  <td><a href="https://www.rcsb.org/structure/3R8H">3R8H</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.01</td>
  <td>AKR1C3 complex with flurbiprofen</td>
  <td><a href="https://www.rcsb.org/structure/3R94">3R94</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>AKR1C3 complex with R-naproxen</td>
  <td><a href="https://www.rcsb.org/structure/3UFY">3UFY</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.73</td>
  <td>AKR1C3 complex with indomethacin at pH 7.5</td>
  <td><a href="https://www.rcsb.org/structure/3UG8">3UG8</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.65</td>
  <td>AKR1C3 complex with indomethacin at pH 6.8</td>
  <td><a href="https://www.rcsb.org/structure/3UGR">3UGR</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.68</td>
  <td>AKR1C3 complexed with 3-phenoxybenzoic acid</td>
  <td><a href="https://www.rcsb.org/structure/3UWE">3UWE</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.85</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3'-[(4-nitronaphthalen-1-yl)amino]benzoic acid</td>
  <td><a href="https://www.rcsb.org/structure/4DBS">4DBS</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.53</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 3-((4 -(trifluoromethyl)phenyl)amino)benzoic acid</td>
  <td><a href="https://www.rcsb.org/structure/4DBU">4DBU</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.8</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3) in complex with NADP+ and 2'-desmethyl-indomethacin</td>
  <td><a href="https://www.rcsb.org/structure/4DBW">4DBW</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>W227F active site mutant of AKR1C3</td>
  <td><a href="https://www.rcsb.org/structure/4DZ5">4DZ5</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.2</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (R)-1-(naphthalen-2-ylsulfonyl)piperidine-3-carboxylic acid (86)</td>
  <td><a href="https://www.rcsb.org/structure/4FA3">4FA3</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)-N-methylbenzamide (80)</td>
  <td><a href="https://www.rcsb.org/structure/4FAL">4FAL</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1H)-yl)sulfonyl)benzoic acid (17)</td>
  <td><a href="https://www.rcsb.org/structure/4FAM">4FAM</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.97</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 1-{4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl}-2-pyrrolidinone</td>
  <td><a href="https://www.rcsb.org/structure/4H7C">4H7C</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.4</td>
  <td>Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with (4-(4-Chlorophenyl)piperazin-1-yl)(morpholino)methanone (24)</td>
  <td><a href="https://www.rcsb.org/structure/4HMN">4HMN</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.5</td>
  <td>17beta-HSD5 in complex with 2-nitro-5-(phenylsulfonyl)phenol</td>
  <td><a href="https://www.rcsb.org/structure/4WDT">4WDT</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>17beta-HSD5 in complex with 4-chloro-N-(4-chlorobenzyl)-5-nitro-1H-pyrazole-3-carboxamide</td>
  <td><a href="https://www.rcsb.org/structure/4WDU">4WDU</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.94</td>
  <td>17beta-HSD5 in complex with 3,6-dihydropyridin-1(2H)-yl(5-methyl-1H-indol-2-yl)methanone</td>
  <td><a href="https://www.rcsb.org/structure/4WDW">4WDW</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.64</td>
  <td>17beta-HSD5 in complex with [4-(2-hydroxyethyl)piperidin-1-yl](5-methyl-1H-indol-2-yl)methanone</td>
  <td><a href="https://www.rcsb.org/structure/4WDX">4WDX</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.6</td>
  <td>AKR1C3 complexed with breakdown product of N-(tert-butyl)-2-(2-chloro-4-(((3-mercapto-5-methyl-4H-1,2,4-triazol-4-yl)amino)methyl)-6-methoxyphenoxy)acetamide</td>
  <td><a href="https://www.rcsb.org/structure/4WRH">4WRH</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.81</td>
  <td>17beta-HSD5 in complex with 4-nitro-2-({4-[3-(trifluoromethyl)phenyl]piperazin-1-yl}methyl)phenol</td>
  <td><a href="https://www.rcsb.org/structure/4XVD">4XVD</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.55</td>
  <td>17beta-HSD5 in complex with 3-pentyl-2-[(pyridin-2-ylmethyl)sulfanyl]-7-(pyrrolidin-1-ylcarbonyl)quinazolin-4(3H)-one</td>
  <td><a href="https://www.rcsb.org/structure/4XVE">4XVE</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.3</td>
  <td>Crystal structure of AKR1C3 complexed with glibenclamide</td>
  <td><a href="https://www.rcsb.org/structure/4YVV">4YVV</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2.3</td>
  <td>Crystal structure of AKR1C3 complexed with glimepiride</td>
  <td><a href="https://www.rcsb.org/structure/4YVX">4YVX</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of AKR1C3 complexed with glicazide</td>
  <td><a href="https://www.rcsb.org/structure/4ZFC">4ZFC</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of AKR1C3 complexed with CAPE</td>
  <td><a href="https://www.rcsb.org/structure/5HNT">5HNT</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal Structure of AKR1C3 complexed with octyl gallate</td>
  <td><a href="https://www.rcsb.org/structure/5HNU">5HNU</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.99</td>
  <td>Crystal structure of AKR1C3 complexed with a pro-drug</td>
  <td><a href="https://www.rcsb.org/structure/5JM5">5JM5</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.88</td>
  <td>Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/6F2U">6F2U</a></td>
  </tr>
  <tr>
  <td>AKR1C3, DDH1, HSD17B5, KIAA0119, PGFS</td>
  <td>Homo sapiens</td>
  <td>1.3</td>
  <td>Potent and selective Aldo-Keto Reductase 1C3 (AKR1C3) inhibitors based on the benzoisoxazole moiety: Application of a Bioisosteric Scaffold Hopping Approach to Flufenamic acid</td>
  <td><a href="https://www.rcsb.org/structure/6F78">6F78</a></td>
  </tr>
  <tr>
  <td>AKR1C4, CHDR</td>
  <td>Homo sapiens</td>
  <td>2.4</td>
  <td>Crystal structure of human 3-alpha hydroxysteroid/dihydrodiol dehydrogenase (AKR1C4) complexed with NADP+</td>
  <td><a href="https://www.rcsb.org/structure/2FVL">2FVL</a></td>
  </tr>
  <tr>
  <td>AKR1C5</td>
  <td>Oryctolagus cuniculus</td>
  <td>2.08</td>
  <td>Crystal structure of rabbit 20alpha hyroxysteroid dehydrogenase in ternary complex with NADP and testosterone</td>
  <td><a href="https://www.rcsb.org/structure/1Q13">1Q13</a></td>
  </tr>
  <tr>
  <td>AKR1C5</td>
  <td>Oryctolagus cuniculus</td>
  <td>1.32</td>
  <td>Binary complex of rabbit 20alpha-hydroxysteroid dehydrogenase with NADPH</td>
  <td><a href="https://www.rcsb.org/structure/1Q5M">1Q5M</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.62</td>
  <td>Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and TESTOSTERONE. RESOLUTION: 1.62 A.</td>
  <td><a href="https://www.rcsb.org/structure/3BUR">3BUR</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.35</td>
  <td>Crystal structure of human Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and HEPES. Resolution: 1.35 A.</td>
  <td><a href="https://www.rcsb.org/structure/3BUV">3BUV</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.79</td>
  <td>Crystal structure of Delta(4)-3-ketosteroid 5-beta-reductase in complex with NADP and glycerol. Resolution: 1.79 A.</td>
  <td><a href="https://www.rcsb.org/structure/3BV7">3BV7</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>2.2</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) in complex with NADPH</td>
  <td><a href="https://www.rcsb.org/structure/3CAQ">3CAQ</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 4-androstenedione</td>
  <td><a href="https://www.rcsb.org/structure/3CAS">3CAS</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-pregnan-3,20-dione</td>
  <td><a href="https://www.rcsb.org/structure/3CAV">3CAV</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.9</td>
  <td>Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and CORTISONE. Resolution 1.90 A.</td>
  <td><a href="https://www.rcsb.org/structure/3CMF">3CMF</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>2.03</td>
  <td>Crystal structure of human liver delta(4)-3-ketosteroid 5beta-reductase (akr1d1) in complex with progesterone and nadp. Resolution: 2.03 A.</td>
  <td><a href="https://www.rcsb.org/structure/3COT">3COT</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>2</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) in complex with NADP+ and 5beta-dihydrotestosterone, Resolution 2.00A</td>
  <td><a href="https://www.rcsb.org/structure/3DOP">3DOP</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.7</td>
  <td>Crystal structure of human liver 5beta-reductase (AKR1D1) in complex with NADP and Finasteride. Resolution 1.70 A</td>
  <td><a href="https://www.rcsb.org/structure/3G1R">3G1R</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.89</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+</td>
  <td><a href="https://www.rcsb.org/structure/3UZW">3UZW</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.64</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and epiandrosterone</td>
  <td><a href="https://www.rcsb.org/structure/3UZX">3UZX</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.83</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and 5beta-dihydrotestosterone</td>
  <td><a href="https://www.rcsb.org/structure/3UZY">3UZY</a></td>
  </tr>
  <tr>
  <td>AKR1D1, SRD5B1</td>
  <td>Homo sapiens</td>
  <td>1.82</td>
  <td>Crystal structure of 5beta-reductase (AKR1D1) E120H mutant in complex with NADP+ and delta4-androstenedione</td>
  <td><a href="https://www.rcsb.org/structure/3UZZ">3UZZ</a></td>
  </tr>
  <tr>
  <td>AKR2A, AFT, AKR2, At4g35450, F15J1.20</td>
  <td>Arabidopsis thaliana</td>
  <td>2.3</td>
  <td>Crystal structure of Ankyrin Repeat Domain of AKR2</td>
  <td><a href="https://www.rcsb.org/structure/4TUM">4TUM</a></td>
  </tr>
  <tr>
  <td>AKR2A, AFT, AKR2, At4g35450, F15J1.20</td>
  <td>Arabidopsis thaliana</td>
  <td>2</td>
  <td>AKR2A ankyrin repeat domain</td>
  <td><a href="https://www.rcsb.org/structure/5EID">5EID</a></td>
  </tr>
  <tr>
  <td>AKR2B5, XYL1, XYLR</td>
  <td>Yamadazyma tenuis</td>
  <td>2.4</td>
  <td>Crystal structure of the Lys-274 to Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NAD+</td>
  <td><a href="https://www.rcsb.org/structure/1YE4">1YE4</a></td>
  </tr>
  <tr>
  <td>AKR2B5, XYL1, XYLR</td>
  <td>Yamadazyma tenuis</td>
  <td>2.3</td>
  <td>Crystal structure of the Lys-274 to Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NADP+</td>
  <td><a href="https://www.rcsb.org/structure/1YE6">1YE6</a></td>
  </tr>
  <tr>
  <td>AKR2E4, akr2e</td>
  <td>Bombyx mori</td>
  <td>1.3</td>
  <td>Crystal structure of Bombyx mori aldo-keto reductase (AKR2E4) in complex with NADP</td>
  <td><a href="https://www.rcsb.org/structure/3WCZ">3WCZ</a></td>
  </tr>
  <tr>
  <td>AKR2E5, 101740031</td>
  <td>Bombyx mori</td>
  <td>2.2</td>
  <td>Crystal structure of aldo-keto reductase (AKR2E5) of the silkworm, Bombyx mori</td>
  <td><a href="https://www.rcsb.org/structure/5AZ0">5AZ0</a></td>
  </tr>
  <tr>
  <td>AKR2E5, 101740031</td>
  <td>Bombyx mori</td>
  <td>2.3</td>
  <td>Crystal structure of aldo-keto reductase (AKR2E5) complexed with NADPH</td>
  <td><a href="https://www.rcsb.org/structure/5AZ1">5AZ1</a></td>
  </tr>
  <tr>
  <td>AKR4C13, AR3, 100857058, ZEAMMB73_Zm00001d038449</td>
  <td>Zea mays</td>
  <td>2.3</td>
  <td>Crystal structure of maize AKR4C13 in complex with NADP and acetate</td>
  <td><a href="https://www.rcsb.org/structure/5JGW">5JGW</a></td>
  </tr>
  <tr>
  <td>AKR4C7, 100037812, ZEAMMB73_Zm00001d042869</td>
  <td>Zea mays</td>
  <td>1.45</td>
  <td>Crystal structure of the apo form of AKR4C7 from maize</td>
  <td><a href="https://www.rcsb.org/structure/5JH1">5JH1</a></td>
  </tr>
  <tr>
  <td>AKR4C7, 100037812, ZEAMMB73_Zm00001d042869</td>
  <td>Zea mays</td>
  <td>1.72</td>
  <td>Crystal structure of the holo form of AKR4C7 from maize</td>
  <td><a href="https://www.rcsb.org/structure/5JH2">5JH2</a></td>
  </tr>
  <tr>
  <td>AKR4C8, At2g37760, F13M22, T8P21.6</td>
  <td>Arabidopsis thaliana</td>
  <td>1.4</td>
  <td>Crystal structure of the plant stress-response enzyme AKR4C8</td>
  <td><a href="https://www.rcsb.org/structure/3H7R">3H7R</a></td>
  </tr>
  <tr>
  <td>AKR4C9, At2g37770, F13M22, T8P21.32</td>
  <td>Arabidopsis thaliana</td>
  <td>1.25</td>
  <td>Crystal structure of the plant stress-response enzyme AKR4C9</td>
  <td><a href="https://www.rcsb.org/structure/3H7U">3H7U</a></td>
  </tr>
  <tr>
  <td>AKR4C13, AR3, 100857058, ZEAMMB73_Zm00001d038449</td>
  <td>Homo sapiens</td>
  <td>2.4</td>
  <td>Structure of the aflatoxin aldehyde reductase in complex with NADPH</td>
  <td><a href="https://www.rcsb.org/structure/2BP1">2BP1</a></td>
  </tr>
  <tr>
  <td>AKR7A2, AFAR, AFAR1, AKR7</td>
  <td>Mus musculus</td>
  <td>2.3</td>
  <td>mouse succinic semialdehyde reductase, AKR7A5</td>
  <td><a href="https://www.rcsb.org/structure/2C91">2C91</a></td>
  </tr>
  <tr>
  <td>Akr7a2, Afar, Akr7a5</td>
  <td>Rattus norvegicus</td>
  <td>1.38</td>
  <td>Aflatoxin aldehyde reductase (AKR7A1) from Rat Liver</td>
  <td><a href="https://www.rcsb.org/structure/1GVE">1GVE</a></td>
  </tr>
  <tr>
  <td>Akr7a3, Afar, Akr7a1</td>
  <td>Homo sapiens</td>
  <td>3</td>
  <td>Crystal structure of human aflatoxin B1 aldehyde reductase member 3</td>
  <td><a href="https://www.rcsb.org/structure/2CLP">2CLP</a></td>
  </tr>
  <tr>
  <td>AKR7A3, AFAR2</td>
  <td>Zea mays</td>
  <td>1.45</td>
  <td>Crystal structure of maize AKR4C13 in P21 space group</td>
  <td><a href="https://www.rcsb.org/structure/5JGY">5JGY</a></td>
  </tr>
  <tr>
  <td>AKR11A, iolS, yxbF, BSU39780, SS92ER</td>
  <td>Bacillus subtilis</td>
  <td>1.8</td>
  <td>Structure of NADPH-dependent family 11 aldo-keto reductase AKR11A(apo)</td>
  <td><a href="https://www.rcsb.org/structure/1PYF">1PYF</a></td>
  </tr>
  <tr>
  <td>AKR11A, iolS, yxbF, BSU39780, SS92ER</td>
  <td>Bacillus subtilis</td>
  <td>2.35</td>
  <td>Structure of NADPH-dependent family 11 aldo-keto reductase AKR11A(holo)</td>
  <td><a href="https://www.rcsb.org/structure/1PZ0">1PZ0</a></td>
  </tr>
  <tr>
  <td>AKR11B, yhdN, BSU09530</td>
  <td>Bacillus subtilis</td>
  <td>2.2</td>
  <td>Structure of NADPH-dependent family 11 aldo-keto reductase AKR11B(holo)</td>
  <td><a href="https://www.rcsb.org/structure/1PZ1">1PZ1</a></td>
  </tr>
  <tr>
  <td>AKR11B4, GOX1615</td>
  <td>Gluconobacter oxydans</td>
  <td>2</td>
  <td>Structure of the glycerol dehydrogenase AKR11B4 from Gluconobacter oxydans</td>
  <td><a href="https://www.rcsb.org/structure/3N2T">3N2T</a></td>
  </tr>
  <tr>
  <td>AKR11C1, BH1011</td>
  <td>Bacillus halodurans</td>
  <td>1.25</td>
  <td>aldo-keto reductase AKR11C1 from Bacillus halodurans (apo form)</td>
  <td><a href="https://www.rcsb.org/structure/1YNP">1YNP</a></td>
  </tr>
  <tr>
  <td>AKR11C1, BH1011</td>
  <td>Bacillus halodurans</td>
  <td>1.3</td>
  <td>aldo-keto reductase AKR11C1 from Bacillus halodurans (holo form)</td>
  <td><a href="https://www.rcsb.org/structure/1YNQ">1YNQ</a></td>
  </tr>
  <tr>
  <td>AKR14A1, gpr, mgrA, yghZ, b3001, JW2970</td>
  <td>Escherichia coli</td>
  <td>2.38</td>
  <td>The apo structure of a bacterial aldo-keto reductase AKR14A1</td>
  <td><a href="https://www.rcsb.org/structure/4AST">4AST</a></td>
  </tr>
  <tr>
  <td>AKR14A1, gpr, mgrA, yghZ, b3001, JW2970</td>
  <td>Escherichia coli</td>
  <td>2.05</td>
  <td>the complex Structure of the bacterial aldo-keto reductase AKR14A1 with NADP and citrate</td>
  <td><a href="https://www.rcsb.org/structure/4AUB">4AUB</a></td>
  </tr>
  <tr>
  <td>PR</td>
  <td>Rauvolfia serpentina</td>
  <td>2.31</td>
  <td>Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding</td>
  <td><a href="https://www.rcsb.org/structure/3UYI">3UYI</a></td>
  </tr>
  <tr>
  <td>PR</td>
  <td>Rauvolfia serpentina</td>
  <td>1.77</td>
  <td>Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding</td>
  <td><a href="https://www.rcsb.org/structure/3V0S">3V0S</a></td>
  </tr>
  <tr>
  <td>PR</td>
  <td>Rauvolfia serpentina</td>
  <td>2.33</td>
  <td>Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding</td>
  <td><a href="https://www.rcsb.org/structure/3V0T">3V0T</a></td>
  </tr>
  <tr>
  <td>PR</td>
  <td>Rauvolfia serpentina</td>
  <td>2.2</td>
  <td>Crystal Structure of Perakine Reductase, Founder Member of a Novel AKR Subfamily with Unique Conformational Changes during NADPH Binding</td>
  <td><a href="https://www.rcsb.org/structure/3V0U">3V0U</a></td>
  </tr>

</thead>
</table>
<p>Visit the TIM-barrel database at <a href="http://www.mrc-lmb.cam.ac.uk/genomes/date/">Database of Tim Barrel Enzymes (DATE)</a></p>
<p><a href="http://www.quimica.urv.es/~pujadas/TIM/">Database for Tim Barrel Proteins</a></p>
<p><a href="http://www.sgc.ox.ac.uk/">Structural Genomics Consortium</a></p>
<p><!-- InstanceEndEditable --></p>
<div id="footer">© The Trustees of the University of Pennsylvania</div>
<p><!-- InstanceEnd --><br></p>
	</div><!-- .entry-content -->


</article><!-- #post-## -->

	</main><!-- .site-main -->


</div><!-- .content-area -->


	<aside id="secondary" class="sidebar widget-area" role="complementary">
		<section id="pages-3" class="widget widget_pages"><h2 class="widget-title">Pages</h2>		<ul>
			<li class="page_item page-item-2"><a href="https://hosting.med.upenn.edu/akr/">Homepage</a></li>
<li class="page_item page-item-22"><a href="https://hosting.med.upenn.edu/akr/barrel-motif/">(αβ)8-barrel Motif</a></li>
<li class="page_item page-item-25"><a href="https://hosting.med.upenn.edu/akr/nomenclature/">Nomenclature System</a></li>
<li class="page_item page-item-50 page_item_has_children"><a href="https://hosting.med.upenn.edu/akr/submitting-akr-sequences/">Submitting AKR Sequences</a>
<ul class="children">
	<li class="page_item page-item-109"><a href="https://hosting.med.upenn.edu/akr/submitting-akr-sequences/submit-a-new-akr-sequence/">Submit a New AKR Sequence</a></li>
</ul>
</li>
<li class="page_item page-item-52 current_page_item"><a href="https://hosting.med.upenn.edu/akr/existing/">Existing AKR Members</a></li>
<li class="page_item page-item-54"><a href="https://hosting.med.upenn.edu/akr/potential/">Potential AKR Members</a></li>
<li class="page_item page-item-58"><a href="https://hosting.med.upenn.edu/akr/family-tree-structures/">Family Tree Structures</a></li>
<li class="page_item page-item-60"><a href="https://hosting.med.upenn.edu/akr/references/">Reference Material</a></li>
<li class="page_item page-item-62 page_item_has_children"><a href="https://hosting.med.upenn.edu/akr/msa/">Multiple Sequence Alignment</a>
<ul class="children">
	<li class="page_item page-item-236"><a href="https://hosting.med.upenn.edu/akr/msa/cofactor-binding-sites/">Cofactor Binding Sites</a></li>
	<li class="page_item page-item-238"><a href="https://hosting.med.upenn.edu/akr/msa/typical-catalytic-tetrad-of-akrs/">Typical Catalytic Tetrad of AKRs</a></li>
	<li class="page_item page-item-240"><a href="https://hosting.med.upenn.edu/akr/msa/loop-structures-in-akrs/">Loop Structures in AKRs</a></li>
	<li class="page_item page-item-259"><a href="https://hosting.med.upenn.edu/akr/msa/akr1-sequence-alignment/">AKR1 Sequence Alignment</a></li>
	<li class="page_item page-item-262"><a href="https://hosting.med.upenn.edu/akr/msa/akr2-sequence-alignment/">AKR2 Sequence Alignment</a></li>
	<li class="page_item page-item-264"><a href="https://hosting.med.upenn.edu/akr/msa/akr3-sequence-alignment/">AKR3 Sequence Alignment</a></li>
	<li class="page_item page-item-266"><a href="https://hosting.med.upenn.edu/akr/msa/akr4-sequence-alignment/">AKR4 Sequence Alignment</a></li>
	<li class="page_item page-item-268"><a href="https://hosting.med.upenn.edu/akr/msa/akr5-sequence-alignment/">AKR5 Sequence Alignment</a></li>
	<li class="page_item page-item-270"><a href="https://hosting.med.upenn.edu/akr/msa/akr6-sequence-alignment/">AKR6 Sequence Alignment</a></li>
	<li class="page_item page-item-272"><a href="https://hosting.med.upenn.edu/akr/msa/akr7-sequence-alignment/">AKR7 Sequence Alignment</a></li>
	<li class="page_item page-item-274"><a href="https://hosting.med.upenn.edu/akr/msa/akr9-sequence-alignment/">AKR9 Sequence Alignment</a></li>
	<li class="page_item page-item-276"><a href="https://hosting.med.upenn.edu/akr/msa/akr11-sequence-alignment/">AKR11 Sequence Alignment</a></li>
	<li class="page_item page-item-278"><a href="https://hosting.med.upenn.edu/akr/msa/akr12-sequence-alignment/">AKR12 Sequence Alignment</a></li>
	<li class="page_item page-item-280"><a href="https://hosting.med.upenn.edu/akr/msa/akr13-sequence-alignment/">AKR13 Sequence Alignment</a></li>
</ul>
</li>
<li class="page_item page-item-64"><a href="https://hosting.med.upenn.edu/akr/human-snps/">Human SNPs</a></li>
<li class="page_item page-item-67"><a href="https://hosting.med.upenn.edu/akr/gene-links/">Gene links</a></li>
<li class="page_item page-item-69"><a href="https://hosting.med.upenn.edu/akr/enzyme-links/">Enzyme Links</a></li>
		</ul>
		</section>	</aside><!-- .sidebar .widget-area -->

		</div><!-- .site-content -->

		<footer id="colophon" class="site-footer" role="contentinfo">


			<div class="site-info">
								<span class="site-title"><a href="https://hosting.med.upenn.edu/" rel="home">AKR Superfamily</a></span>
				<a href="https://www.med.upenn.edu/">www.med.upenn.edu</a>
			</div><!-- .site-info -->
		</footer><!-- .site-footer -->
	</div><!-- .site-inner -->
</div><!-- .site -->

<script type="text/javascript" src="./pdb_list_files/jquery.form.min.js"></script>
<script type="text/javascript">
/* <![CDATA[ */
var _wpcf7 = {"recaptcha":{"messages":{"empty":"Please verify that you are not a robot."}}};
/* ]]> */
</script>
<script type="text/javascript" src="./pdb_list_files/scripts.js"></script>
<script type="text/javascript" src="./pdb_list_files/skip-link-focus-fix.js"></script>
<script type="text/javascript">
/* <![CDATA[ */
var screenReaderText = {"expand":"expand child menu","collapse":"collapse child menu","partials":"\/wp-content\/themes\/twentysomething\/partials\/"};
/* ]]> */
</script>
<script type="text/javascript" src="./pdb_list_files/functions.js"></script>
<script type="text/javascript" src="./pdb_list_files/wp-embed.min.js"></script>


</body><grammarly-desktop-integration data-grammarly-shadow-root="true"></grammarly-desktop-integration></html>
